[开放获取]    窄谱中波紫外线光疗皮肤科临床应用指南（2026版）

doi:10.35541/cjd.20250733

Abstract

Abstract: 【Abstract】 Narrowband ultraviolet B （NB-UVB） is a commonly used phototherapy modality in dermatology and has become a first-line or important adjuvant treatment for various skin diseases. This guideline was formulated by the Dermatology Professional Committee of Chinese Research Hospital Society and the China Dermatologist Association through expert discussions, based on the latest medical evidence and clinical practice experience regarding NB-UVB phototherapy in China and other countries in recent years. This guideline outlines the light source characteristics, mechanisms of action, indications, and contraindications of NB-UVB phototherapy （including 311-nm and 308-nm light sources）, with a focus on standardizing individualized treatment protocols, combination therapy strategies, and phototherapy precautions for special populations in the treatment of common indications such as vitiligo, psoriasis, mycosis fungoides, and atopic dermatitis. Furthermore, it addresses key issues in clinical practice, including the management of adverse reactions, home phototherapy management, and equipment maintenance, with the aim of providing scientific and standardized guidance for the clinical application of NB-UVB in dermatology.

Key words: Ultraviolet therapy, Narrowband ultraviolet B, 308-nm light, Therapeutics, Guideline

Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline for the clinical application of narrowband ultraviolet B phototherapy in dermatology （2026 edition）[J]. Chinese Journal of Dermatology, 2026, 59(7): 595-610.doi:10.35541/cjd.20250733

References ［132］

［1］	Elmets CA, Lim HW, Stoff B, et al. Joint American Academy of Dermatology⁃National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy［J］. J Am Acad Dermatol, 2019,81（3）:775⁃804. DOI: 10.1016/j.jaad.2019.04.042.
［2］	Poolsuwan P, Churee C, Pattamadilok B. Comparative efficacy between localized 308⁃nm excimer light and targeted 311⁃nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single⁃blind comparison study［J］. Photodermatol Photoimmunol Photomed, 2021,37（2）:123⁃130. DOI: 10.1111/phpp.12619.
［3］	Yoshiki R, Kabashima K, Sakabe J, et al. The mandatory role of IL⁃10⁃producing and OX40 ligand⁃expressing mature Langerhans cells in local UVB⁃induced immunosuppression［J］. J Immunol, 2010,184（10）:5670⁃5677. DOI:10.4049/jimmunol. 0903254.
［4］	Rácz E, Prens EP, Kurek D, et al. Effective treatment of psoriasis with narrow⁃band UVB phototherapy is linked to suppression of the IFN and Th17 pathways［J］. J Invest Dermatol, 2011,131（7）:1547⁃1558. DOI: 10.1038/jid.2011.53.
［5］	Morita A. Current developments in phototherapy for psoriasis［J］. J Dermatol, 2018,45（3）:287⁃292. DOI: 10.1111/1346⁃8138.14213.
［6］	Weatherhead SC, Farr PM, Jamieson D, et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation［J］. J Invest Dermatol, 2011,131（9）:1916⁃1926. DOI: 10.1038/jid.2011.134.
［7］	Goldstein NB, Koster MI, Hoaglin LG, et al. Narrow band ultraviolet B treatment for human vitiligo is associated with proliferation, migration, and differentiation of melanocyte precursors［J］. J Invest Dermatol, 2015,135（8）:2068⁃2076. DOI: 10.1038/jid.2015.126.
［8］	Dong D, Jiang M, Xu X, et al. The effects of NB⁃UVB on the hair follicle⁃derived neural crest stem cells differentiating into melanocyte lineage in vitro［J］. J Dermatol Sci, 2012,66（1）:20⁃28. DOI: 10.1016/j.jdermsci.2012.01.012.
［9］	Yardman⁃Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells［J］. Exp Dermatol, 2021,30（4）:560⁃571. DOI: 10.1111/exd.14260.
［10］	Goldstein NB, Steel A, Barbulescu CC, et al. Melanocyte precursors in the hair follicle bulge of repigmented vitiligo skin are controlled by RHO⁃GTPase, KCTD10, and CTNNB1 signaling［J］. J Invest Dermatol, 2021,141（3）:638⁃647. DOI: 10.1016/j.jid.2020.07.016.
［11］	Vieyra⁃Garcia PA, Wolf P. A deep dive into UV⁃based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer［J］. Pharmacol Ther, 2021,222:107784. DOI: 10.1016/j.pharmthera.2020.107784.
［12］	Giustozzi MI, Torre AC, Ritchie C, et al. Phototherapy as an alternative in the treatment of chronic spontaneous urticaria［J］. Front Allergy, 2024,5:1468983. DOI: 10.3389/falgy.2024.1468983.
［13］	Navarro⁃Bielsa A, Gracia⁃Cazaña T, Campo RD, et al. Analysis of the modification of skin and gut microbiota in psoriasis patients treated with phototherapy［J］. Photochem Photobiol Sci, 2024,23（9）:1807⁃1810. DOI: 10.1007/s43630⁃024⁃00628⁃0.
［14］	Lossius AH, Sundnes O, Ingham AC, et al. Shifts in the skin microbiota after UVB treatment in adult atopic dermatitis［J］. Dermatology, 2022,238（1）:109⁃120. DOI: 10.1159/000515236.
［15］	Hong SP, Kim MJ, Jung MY, et al. Biopositive effects of low⁃dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement［J］. J Invest Dermatol, 2008,128（12）:2880⁃2887. DOI: 10.1038/jid.2008.169.
［16］	Fowler Joanna C, Sood Roshan K, George C, et al. Mutation burden of narrowband ultraviolet B phototherapy （NB⁃UVB） in human skin: relevance to NB⁃UVB lifetime exposures and skin cancer surveillance［J］. Br J Dermatol, 2025,193（4）:718⁃728. DOI: 10.1093/bjd/ljaf173.
［17］	Totonchy MB, Chiu MW. UV⁃based therapy［J］. Dermatol Clin, 2014,32（3）:399⁃413. DOI: 10.1016/j.det.2014.03.003.
［18］	Victoria G, Ling Tsui C, Parastoo B, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022［J］. Br J Dermatol, 2022,187（3）:295⁃308. DOI: 10.1111/bjd.21669.
［19］	中国医师协会皮肤科医师分会规范化诊疗工作委员会. 窄谱中波紫外线家庭光疗临床应用专家共识［J］. 中华皮肤科杂志, 2019,52（3）:156⁃161. DOI: 10.3760/cma.j.issn.0412⁃4030. 2019.03.002.
［20］	Bae JM, Eun SH, Oh SH, et al. The 308⁃nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: a population⁃based retrospective cohort study［J］. Pigment Cell Melanoma Res, 2019,32（5）:714⁃718. DOI: 10. 1111/pcmr.12781.
［21］	Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. DOI: 10.1016/j.jaad.2016.12.041.
［22］	Hofer A, Hassan AS, Legat FJ, et al. Optimal weekly frequency of 308⁃nm excimer laser treatment in vitiligo patients［J］. Br J Dermatol, 2005,152（5）:981⁃985. DOI: 10.1111/j.1365⁃2133. 2004.06321.x.
［23］	中国中西医结合学会皮肤性病专业委员会色素病学组, 中华医学会皮肤性病学分会白癜风研究中心, 中国医师协会皮肤科医师分会色素病专委会. 白癜风诊疗共识（2024版）［J］. 中华皮肤科杂志, 2024,57（12）:1065⁃1070. DOI: 10.35541/cjd. 20240260.
［24］	Bae J M, Hann S⁃K. Laser treatments for vitiligo［J］. Medical Lasers, 2016, 5（2）: 63⁃70. DOI:10.25289/ML.2016.5.2.63.
［25］	中华医学会皮肤性病学分会毛发学组, 中国康复医学会皮肤病康复专业委员会毛发疾病康复学组. 中国雄激素性秃发诊疗指南（2023）［J］. 临床皮肤科杂志, 2024, 53（12）: 752⁃758. DOI: 10.16761/j.cnki.1000⁃4963.2024.12.015.
［26］	Esmat SM, El⁃Mofty M, Rasheed H, et al. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo⁃types （Ⅲ⁃Ⅴ）: a double⁃blind, randomized, placebo⁃controlled, prospective, multicenter study［J］. Photodermatol Photoimmunol Photomed, 2022,38（3）:277⁃287. DOI: 10.1111/phpp.12749.
［27］	Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. DOI: 10.1159/000439563.
［28］	Hu Z, Lu L, Feng J, et al. Low⁃dose baricitinib plus narrow⁃band ultraviolet B for the treatment of progressive non⁃segmental vitiligo: a prospective, controlled, open⁃label study［J］. Pigment Cell Melanoma Res, 2025,38（1）:e13209. DOI: 10.1111/pcmr. 13209.
［29］	Wei Z, Shengrui Z, Jinfa D, et al. Short⁃term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo［J］. Arch Dermatol Res, 2025,317（1）:252. DOI: 10.1007/s00403⁃024⁃03717⁃3.
［30］	Guo X, Zhang D, Chen G, et al. The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial［J］. J Dermatolog Treat, 2025,36（1）:2479567. DOI: 10.1080/09546634.2025.2479567.
［31］	Zhongyi X, Yijie X, Yiyi L, et al. A prospective observational study of oral abrocitinib and narrow⁃band ultraviolet⁃B in refractory progressive vitiligo［J］. J Am Acad Dermatol, 2024,91（3）:590⁃592. DOI: 10.1016/j.jaad.2024.05.078.
［32］	Gao J, Li Q, Huang H, et al. Combined tofacitinib citrate and 308⁃nm excimer laser treatment for vitiligo: a pilot study［J］. Clin Exp Dermatol, 2025,50（5）:940⁃945. DOI: 10.1093/ced/llae532.
［33］	Pandya Amit G, Harris John E, Mark L, et al. Addition of narrow⁃band UVB phototherapy to ruxolitinib cream in patients with vitiligo［J］. J Invest Dermatol, 2022,142（12）:3352⁃3355. DOI: 10.1016/j.jid.2022.05.1093.
［34］	Duplaine A, Tannous J, Seneschal J, et al. Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapy［J］. Ann Dermatol Venereol, 2025,152（2）:103352. DOI: 10. 1016/j.annder.2025.103352.
［35］	Ju HJ, Han JH, Kim M, et al. The long⁃term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo［J］. J Am Acad Dermatol, 2021,84（6）:1619⁃1627. DOI: 10.1016/j.jaad.2021.01.067.
［36］	Hu M, Liao K, Lei W, et al. The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: a systematic review and meta⁃analysis［J］. Int Immunopharmacol, 2021,98:107910. DOI: 10.1016/j.intimp. 2021.107910.
［37］	Liu X, Yao Z, Wang Y, et al. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: a systematic review of randomized trials and within⁃patient studies［J］. Int Immunopharmacol, 2022,109:108789. DOI: 10.1016/j.intimp.2022.108789.
［38］	Savant SS, Savant SS. Retrospective analysis of ultrathin skin grafting over carbon dioxide ablated lesions supplemented with excimer lamp （308 nm） therapy in stable vitiligo［J］. Indian J Dermatol Venereol Leprol, 2023:1⁃8. DOI: 10.25259/IJDVL_408_2022.
［39］	Guo C, Gu X, Zhang J, et al. Efficacy of fire needle combined with 308 nm excimer laser therapy for vitiligo: a systematic review and meta⁃analysis of randomized controlled trials［J］. J Cosmet Dermatol, 2024,23（8）:2592⁃2602. DOI: 10.1111/jocd. 16308.
［40］	Almutawa F, Alnomair N, Wang Y, et al. Systematic review of UV⁃based therapy for psoriasis［J］. Am J Clin Dermatol, 2013,14（2）:87⁃109. DOI: 10.1007/s40257⁃013⁃0015⁃y.
［41］	Archier E, Devaux S, Castela E, et al. Efficacy of psoralen UVA therapy vs. narrowband UVB therapy in chronic plaque psoriasis: a systematic literature review［J］. J Eur Acad Dermatol Venereol, 2012,26 Suppl 3:11⁃21. DOI: 10.1111/j.1468⁃3083.2012.04519.x.
［42］	Yu Y, Yi X, Zhang Y, et al. Comparison of different incremental dose regimens of narrow⁃band ultraviolet B in skin typesⅢ to Ⅴ: a prospective, randomized, single⁃blind, parallel study in patients with psoriasis［J］. J Am Acad Dermatol, 2021,84（4）:1136⁃1138. DOI: 10.1016/j.jaad.2020.06.993.
［43］	Almutawa F, Thalib L, Hekman D, et al. Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2015,31（1）:5⁃14. DOI: 10.1111/phpp.12092.
［44］	Mudigonda T, Dabade TS, Feldman SR. A review of targeted ultraviolet B phototherapy for psoriasis［J］. J Am Acad Dermatol, 2012,66（4）:664⁃672. DOI: 10.1016/j.jaad.2011.07.011.
［45］	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）［J］. 中华皮肤科杂志, 2023,56（7）:573⁃625. DOI: 10.35541/cjd.20220839.
［46］	Hauptman M, Othmani AE, Pazhyanur S, et al. Narrowband⁃ultraviolet B phototherapy for psoriasis treatment in skin of color: a systematic review and meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2025,41（5）:e70051. DOI: 10.1111/phpp.70051.
［47］	Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque⁃type psoriasis: a randomized, placebo⁃controlled study［J］. J Am Acad Dermatol, 2006,54（6）:1013⁃1018. DOI: 10.1016/j.jaad.2006.01.004.
［48］	Farahnik B, Patel V, Beroukhim K, et al. Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability［J］. Psoriasis （Auckl）, 2016,6:105⁃111. DOI: 10.2147/PTT.S98952.
［49］	中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物制剂及小分子药物治疗指南（2024版）［J］. 中华皮肤科杂志, 2024,57（11）:976⁃997. DOI: 10.35541/cjd.20240294.
［50］	Surabhi D, Rajiv K, Priyadarshini S, et al. Tazarotene gel with narrow⁃band UVB phototherapy: a synergistic combination in psoriasis［J］. An Bras Dermatol, 2018,93（3）:385⁃390. DOI: 10.1590/abd1806⁃4841.20186723.
［51］	Phan K, Ramachandran V, Fassihi H, et al. Comparison of narrowband UV⁃B with psoralen⁃UV⁃A phototherapy for patients with early⁃stage mycosis fungoides: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（3）:335⁃341. DOI: 10.1001/jamadermatol.2018.5204.
［52］	Garfinkel V, Reisch JS, Goff HW. A retrospective comparison between home and in⁃office NB⁃UVB efficacy for patients with mycosis fungoides［J］. Photodermatol Photoimmunol Photomed, 2024,40（6）:e13009. DOI: 10.1111/phpp.13009.
［53］	Pavlotsky F, Dawood M, Barzilai A. Potential of narrow⁃band ultraviolet B to induce sustained durable complete remission off⁃therapy in patients with stage I mycosis fungoides［J］. J Am Acad Dermatol, 2019,80（6）:1550⁃1555. DOI: 10.1016/j.jaad. 2018.05.023.
［54］	Olsen Elise A, Emilia H, Thomas A, et al. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium［J］. J Am Acad Dermatol, 2016,74（1）:27⁃58. DOI: 10.1016/j.jaad.2015.09.033.
［55］	Grandi V, Baldo A, Berti E, et al. Italian expert⁃based recommendations on the use of photo（chemo）therapy in the management of mycosis fungoides: results of an e⁃Delphi consensus［J］. Photodermatol Photoimmunol Photomed, 2021,37（4）:334⁃342. DOI: 10.1111/phpp.12658.
［56］	Grandi V, Fava P, Rupoli S, et al. Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas［J］. J Eur Acad Dermatol Venereol, 2018,32（5）:683⁃691. DOI: 10.1111/jdv.14668.
［57］	Sosh D, Hyde J, Dulmage B. The efficacy of 308⁃nm excimer laser in the treatment of mycosis fungoides［J］. Int J Dermatol, 2023,62（2）:e92⁃e93. DOI: 10.1111/ijd.16050.
［58］	Nisticò S, Costanzo A, Saraceno R, et al. Efficacy of monochromatic excimer laser radiation （308 nm） in the treatment of early stage mycosis fungoides［J］. Br J Dermatol, 2004,151（4）:877⁃879. DOI: 10.1111/j.1365⁃2133.2004.06178.x.
［59］	Mori M, Campolmi P, Mavilia L, et al. Monochromatic excimer light （308 nm） in patch⁃stage ⅠA mycosis fungoides［J］. J Am Acad Dermatol, 2004,50（6）:943⁃945. DOI: 10.1016/j.jaad. 2004.01.047.
［60］	Deaver D, Cauthen A, Cohen G, et al. Excimer laser in the treatment of mycosis fungoides［J］. J Am Acad Dermatol, 2014,70（6）:1058⁃1060. DOI: 10.1016/j.jaad.2014.01.915.
［61］	Jin SP, Jeon YK, Cho KH, et al. Excimer laser therapy （308 nm） for mycosis fungoides palmaris et plantaris: a skin⁃directed and anatomically feasible treatment［J］. Br J Dermatol, 2010,163（3）:651⁃653. DOI: 10.1111/j.1365⁃2133.2010.09793.x.
［62］	《蕈样肉芽肿治疗中国专家共识（2023）》编写专家组. 蕈样肉芽肿治疗中国专家共识（2023）［J］. 中华皮肤科杂志, 2023,56（5）:402⁃409. DOI: 10.35541/cjd.20220909.
［63］	Qin Y, Lin Y, Chen Z, et al. Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early⁃stage mycosis fungoides and the association with plaque lesions［J］. J Evid Based Med, 2024,17（2）:390⁃398. DOI: 10.1111/jebm.12623.
［64］	Lokitz ML, Wong HK. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides［J］. Photodermatol Photoimmunol Photomed, 2007,23（6）:255⁃257. DOI: 10.1111/j.1600⁃0781.2007.00315.x.
［65］	D'Acunto C, Gurioli C, Neri I. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB⁃NB［J］. J Dermatolog Treat, 2010,21（1）:45⁃48. DOI: 10.3109/09546630 903103980.
［66］	Wollenberg A, Barbarot S, Bieber T, et al. Consensus⁃based European guidelines for treatment of atopic eczema （atopic dermatitis） in adults and children: partⅠ［J］. J Eur Acad Dermatol Venereol, 2018,32（5）:657⁃682. DOI: 10.1111/jdv. 14891.
［67］	Wollenberg A, Oranje A, Deleuran M, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients［J］. J Eur Acad Dermatol Venereol, 2016,30（5）:729⁃747. DOI: 10.1111/jdv.13599.
［68］	Reynolds NJ, Franklin V, Gray JC, et al. Narrow⁃band ultraviolet B and broad⁃band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial［J］. Lancet, 2001,357（9273）:2012⁃2016. DOI: 10.1016/S0140⁃6736（00）05114⁃X.
［69］	Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents［J］. J Am Acad Dermatol, 2014,71（2）:327⁃349. DOI: 10.1016/j.jaad.2014.03. 030.
［70］	Musters AH, Mashayekhi S, Harvey J, et al. Phototherapy for atopic eczema［J］. Cochrane Database Syst Rev, 2021,10:CD013870. DOI: 10.1002/14651858.CD013870.pub2.
［71］	Garritsen FM, Brouwer MWD, Limpens J, et al. Photo（chemo）therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research［J］. Br J Dermatol, 2014,170（3）:501⁃513. DOI: 10.1111/bjd. 12645.
［72］	Mordehai YB, Barzilai A, Dalal A, et al. Long⁃term narrowband UV⁃B efficacy in moderate to severe atopic dermatitis［J］. Dermatitis, 2022,33（4）:282⁃286. DOI: 10.1097/DER.0000000 000000810.
［73］	Chen J, Zeng X, Chen Q, et al. Efficacy of NB⁃UVB as add⁃on therapy to antihistamine in the treatment of chronic urticaria: a systematic review and meta⁃analysis［J］. Dermatol Ther （Heidelb）, 2021,11（3）:681⁃694. DOI: 10.1007/s13555⁃021⁃00510⁃2.
［74］	Vestergaard C, Toubi E, Maurer M, et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1⁃antihistamines: an expert opinion［J］. Eur J Dermatol, 2017,27（1）:10⁃19. DOI: 10.1684/ejd.2016.2905.
［75］	Hong JY, Kim MH, Lee JH, et al. Phototherapy may be a useful adjuvant therapy for retractable chronic spontaneous urticaria: a systematic review［J］. Photochem Photobiol, 2020,96（4）:738⁃740. DOI: 10.1111/php.13260.
［76］	Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options［J］. J Am Acad Dermatol, 2016,75（3）:467⁃479. DOI: 10.1016/j.jaad.2015.03.055.
［77］	Cunningham L, Kirby B, Lally A, et al. The efficacy of PUVA and narrowband UVB phototherapy in the management of generalised granuloma annulare［J］. J Dermatolog Treat, 2016,27（2）:136⁃139. DOI: 10.3109/09546634.2015.1087461.
［78］	Nisticò SP, Saraceno R, Schipani C, et al. Different applications of monochromatic excimer light in skin diseases［J］. Photomed Laser Surg, 2009,27（4）:647⁃654. DOI: 10.1089/pho.2008.2317.
［79］	Solak B, Dikicier BS, Erdem T. Narrow band ultraviolet B for the treatment of generalized lichen planus［J］. Cutan Ocul Toxicol, 2016,35（3）:190⁃193. DOI: 10.3109/15569527.2015.1074587.
［80］	Iraji F, Faghihi G, Asilian A, et al. Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: a randomized clinical trial［J］. J Res Med Sci, 2011,16（12）:1578⁃1582.
［81］	Weber B, Marquart E, Radakovic S, et al. Effectiveness of narrowband UVB phototherapy and psoralen plus UVA photochemotherapy in the treatment of generalized lichen planus: results from a large retrospective analysis and an update of the literature［J］. Photodermatol Photoimmunol Photomed, 2022,38（2）:104⁃111. DOI: 10.1111/phpp.12723.
［82］	Mithra S, Kumar P, Sowmiya R. Comparative study of the efficacy of azathioprine, dapsone, and NB⁃UVB phototherapy as steroid⁃sparing modalities in generalised lichen planus［J］. Indian J Dermatol Venereol Leprol, 2025,91（1）:59⁃64. DOI: 10.25259/IJDVL_383_2023.
［83］	Pathoulas James T, Flanagan Kelly E, Su Mack Y, et al. A prospective pilot study of narrowband UV⁃B treatment of lichen planopilaris［J］. J Am Acad Dermatol, 2022,87（3）:703⁃705. DOI: 10.1016/j.jaad.2022.04.054.
［84］	Navarini AA, Kolios AGA, Prinz⁃Vavricka BM, et al. Low⁃dose excimer 308⁃nm laser for treatment of lichen planopilaris［J］. Arch Dermatol, 2011,147（11）:1325⁃1326. DOI: 10.1001/archdermatol.2011.335.
［85］	Liu W, Sun L, Yang H, et al. Treatment of oral lichen planus using 308⁃nm excimer laser［J］. Dermatol Ther, 2017,30（5）DOI: 10.1111/dth.12510.
［86］	Tamagawa⁃Mineoka R, Katoh N, Ueda E, et al. Narrow⁃band ultraviolet B phototherapy in patients with recalcitrant nodular prurigo［J］. J Dermatol, 2007,34（10）:691⁃695. DOI: 10.1111/j.1346⁃8138.2007.00360.x.
［87］	Agaoglu E, Erdogan HK, Acer E, et al. Efficacy and safety of narrowband ultraviolet B phototherapy for prurigo nodularis: a tertiary center experience［J］. An Bras Dermatol, 2025,100（1）:38⁃44. DOI: 10.1016/j.abd.2024.02.007.
［88］	Romana K, Alexandra G, Angelika H, et al. Narrowband⁃ultraviolet B vs broadband⁃ultraviolet B in treatment of chronic pruritus: a randomized, single⁃blinded, non⁃inferiority study［J］. Acta Derm Venereol, 2023,103:adv9403. DOI: 10.2340/actadv.v103.9403.
［89］	Peng L, Shao Y, Hu Y, et al. Efficacy and safety of 308⁃nanometer light⁃emitting diode phototherapy for prurigo nodularis: a randomized and self⁃controlled clinical trial［J］. J Am Acad Dermatol, 2025,94（1）:e27⁃e28. DOI:10.1016/j.jaad.2025.05.1464.
［90］	Lambert WC, Everett MA. The nosology of parapsoriasis［J］. J Am Acad Dermatol, 1981,5（4）:373⁃395. DOI: 10.1016/s0190⁃9622（81）70100⁃2.
［91］	Aydogan K, Karadogan SK, Tunali S, et al. Narrowband UVB phototherapy for small plaque parapsoriasis［J］. J Eur Acad Dermatol Venereol, 2006,20（5）:573⁃577. DOI: 10.1111/j.1468⁃3083.2006.01567.x.
［92］	Bellinato F, Maurelli M, Gisondi P, et al. A systematic review of treatments for pityriasis lichenoides［J］. J Eur Acad Dermatol Venereol, 2019,33（11）:2039⁃2049. DOI: 10.1111/jdv.15813.
［93］	Agaoglu E, Erdogan HK, Acer E, et al. Narrowband ultraviolet B phototherapy for pityriasis lichenoides: a real⁃life experience［J］. Photodermatol Photoimmunol Photomed, 2023,39（5）:520⁃526. DOI: 10.1111/phpp.12895.
［94］	Salah EM, Bedair NI, El⁃Rahim SKA, et al. Efficacy and safety of excimer light （308 nm） in the treatment of pityriasis lichenoides chronica［J］. Photodermatol Photoimmunol Photomed, 2024,40（3）:e12964. DOI: 10.1111/phpp.12964.
［95］	Bilsland D, George SA, Gibbs NK, et al. A comparison of narrow band phototherapy （TL⁃01） and photochemotherapy （PUVA） in the management of polymorphic light eruption［J］. Br J Dermatol, 1993,129（6）:708⁃712. DOI: 10.1111/j.1365⁃2133. 1993.tb03337.x.
［96］	邓蕙妍, 陈教全, 李华平, 等. 特发性光线性皮肤病的光硬化治疗［J］. 中华皮肤科杂志, 2023,56（12）:1091⁃1095. DOI: 10.35541/cjd.20230347.
［97］	Combalia A, Fernández⁃Sartorio C, Fustà X, et al. Successful short desensitization treatment protocol with narrowband UVB phototherapy （TL⁃01） in polymorphic light eruption［J］. Actas Dermosifiliogr, 2017,108（8）:752⁃757. DOI: 10.1016/j.ad.2017. 04.004.
［98］	Ma L , Zhang Q , Hu Y ,et al. Evaluation of narrow band ultraviolet B phototherapy in the treatment of chronic actinic dermatitis in Chinese patients［J］. Dermatol Ther, 2017,30（6）:e12528. DOI: 10.1111/dth.12528.
［99］	中国研究型医院学会皮肤科学专业委员会, 中国医师协会皮肤科医师分会. 慢性光化性皮炎诊疗专家共识（2023版）［J］. 中华皮肤科杂志, 2023,56（12）:1096⁃1106. DOI: 10.35541/cjd.20230433.
［100］	Calzavara⁃Pinton P, Zane C, Rossi M, et al. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria［J］. J Am Acad Dermatol, 2012,67（1）:5⁃9. DOI: 10.1016/j.jaad.2011.01.030.
［101］	Markowitz ME, Noyman Y, Khanimov I, et al. Efficacy of therapies for solar urticaria: a systematic review and meta⁃analysis［J］. J Clin Med, 2025,14（16）:5736. DOI: 10.3390/jcm14165736.
［102］	Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2017,153（7）:666⁃674. DOI: 10.1001/jamadermatol.2017.0002.
［103］	Casacci M, Thomas P, Pacifico A, et al. Comparison between 308⁃nm monochromatic excimer light and narrowband UVB phototherapy （311⁃313 nm） in the treatment of vitiligo⁃a multicentre controlled study［J］. J Eur Acad Dermatol Venereol, 2007,21（7）:956⁃963. DOI: 10.1111/j.1468⁃3083.2007.02151.x.
［104］	Bae JM, Hong BY, Lee JH, et al. The efficacy of 308⁃nm excimer laser/light （EL） and topical agent combination therapy versus EL monotherapy for vitiligo: a systematic review and meta⁃analysis of randomized controlled trials （RCTs）［J］. J Am Acad Dermatol, 2016,74（5）:907⁃915. DOI: 10.1016/j.jaad.2015.11. 044.
［105］	Sun Y, Wu Y, Xiao B, et al. Treatment of 308⁃nm excimer laser on vitiligo: a systemic review of randomized controlled trials［J］. J Dermatolog Treat, 2015,26（4）:347⁃353. DOI: 10.3109/0954 6634.2014.991268.
［106］	Alshiyab D, Ba⁃Shammakh SA, Al⁃Fakih A, et al. Efficacy and safety of 308⁃nm excimer lamp combined with tacrolimus 0.1% ointment vs tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial［J］. J Dermatolog Treat, 2024,35（1）:2296851. DOI: 10. 1080/09546634.2023.2296851.
［107］	Majid I, Imran S. Excimer light therapy in childhood segmental vitiligo: early treatment gives better results［J］. Dermatol Ther, 2020,33（3）:e13408. DOI: 10.1111/dth.13408.
［108］	Acer E, Erdoğan HK, Ağaoğlu E, et al. Narrowband ultraviolet B phototherapy for generalized granuloma annulare: real⁃life experience and review of the literature［J］. J Cutan Med Surg, 2025,29（1）:24⁃28. DOI: 10.1177/12034754241290811.
［109］	Vergilis⁃Kalner IJ, Mann DJ, Wasserman J, et al. Pityriasis rubra pilaris sensitive to narrow band⁃ultraviolet B light therapy［J］. J Drugs Dermatol, 2009,8（3）:270⁃273.
［110］	Camela E, Miano C, Caterino PD, et al. Erythrodermic pityriasis rubra pilaris treatment: two case reports and literature review［J］. Dermatol Ther, 2020,33（6）:e14223. DOI: 10.1111/dth. 14223.
［111］	Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study［J］. J Am Acad Dermatol, 1995,33（6）:996⁃999. DOI: 10.1016/0190⁃9622（95）90293⁃7.
［112］	Jairath V, Mohan M, Jindal N, et al. Narrowband UVB phototherapy in pityriasis rosea［J］. Indian Dermatol Online J, 2015,6（5）:326⁃329. DOI: 10.4103/2229⁃5178.164480.
［113］	Pirkhammer D, Seeber A, Hönigsmann H, et al. Narrow⁃band ultraviolet B （ATL⁃01） phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis［J］. Br J Dermatol, 2000,143（5）:964⁃968. DOI: 10.1046/j.1365⁃2133.2000.03828.x.
［114］	Xu H, Liu Q, Li Y, et al. Acitretin combined with NB⁃UVB in the treatment of cutaneous CD30⁃positive anaplastic large cell lymphoma［J］. Dermatol Ther, 2019,32（2）:e12834. DOI: 10. 1111/dth.12834.
［115］	Reddy V, Thibodeaux Q, Bhutani T, et al. Lymphomatoid papulosis successfully managed with excimer laser maintenance therapy［J］. JAAD Case Rep, 2020,6（6）:495⁃497. DOI: 10. 1016/j.jdcr.2020.04.005.
［116］	Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review［J］. Am J Kidney Dis, 2017,70（5）:638⁃655. DOI: 10.1053/j.ajkd.2017.05.018.
［117］	Baldo A, Sammarco E, Plaitano R, et al. Narrowband （TL⁃01） ultraviolet B phototherapy for pruritus in polycythaemia vera［J］. Br J Dermatol, 2002,147（5）:979⁃981. DOI: 10.1046/j.1365⁃2133.2002.04983.x.
［118］	Gattringer C, Müller H, Steurer M, et al. Narrowband UVB therapy for the treatment of pruritus in hypereosinophilic syndrome: clinical report and review of the literature on phototherapy［J］. J Am Acad Dermatol, 2012,67（5）:e210⁃e213. DOI: 10.1016/j.jaad.2012.02.043.
［119］	Ozden MG, Aydin F, Sentürk N, et al. Narrow⁃band ultraviolet B as a potential alternative treatment for resistant psychogenic excoriation: an open⁃label study［J］. Photodermatol Photoimmunol Photomed, 2010,26（3）:162⁃164. DOI: 10.1111/j.1600⁃0781. 2010.00512.x.
［120］	Pérez⁃Pérez L, Allegue F, Fabeiro J, et al. Notalgia paresthesica successfully treated with narrow⁃band UVB: report of five cases［J］. J Eur Acad Dermatol Venereol, 2010,24（6）:730⁃732. DOI: 10.1111/j.1468⁃3083.2009.03479.x.
［121］	Kwah Y, Chong W, Theng CT, et al. Treatment of progressive macular hypomelanosis with narrow⁃band ultraviolet B phototherapy［J］. Photodermatol Photoimmunol Photomed, 2010,26（3）:153⁃155. DOI: 10.1111/j.1600⁃0781.2010.00504.x.
［122］	Sim JH, Lee DJ, Lee JS, et al. Comparison of the clinical efficacy of NBUVB and NBUVB with benzoyl peroxide/clindamycin in progressive macular hypomelanosis［J］. J Eur Acad Dermatol Venereol, 2011,25（11）:1318⁃1323. DOI: 10. 1111/j.1468⁃3083.2011.03980.x.
［123］	Kim M, Kim G, Cho H, et al. Narrowband UVB treatment of progressive macular hypomelanosis［J］. J Am Acad Dermatol, 2012,66（4）:598⁃605. DOI: 10.1016/j.jaad.2011.04.010.
［124］	Kreeshan FC, Madan V. Idiopathic guttate hypomelanosis treated with 308⁃nm excimer light and topical bimatoprost［J］. J Cutan Aesthet Surg, 2021,14（1）:115⁃117. DOI: 10.4103/JCAS.JCAS_112_20.
［125］	Zhang P, Wu MX. A clinical review of phototherapy for psoriasis［J］. Lasers Med Sci, 2018,33（1）:173⁃180. DOI: 10.1007/s10103⁃017⁃2360⁃1.
［126］	Li Y, Cao Z, Guo J, et al. Assessment of efficacy and safety of UV⁃based therapy for psoriasis: a network meta⁃analysis of randomized controlled trials［J］. Ann Med, 2022,54（1）:159⁃169. DOI: 10.1080/07853890.2021.2022187.
［127］	Zubair R, Hamzavi IH. Phototherapy for vitiligo［J］. Dermatol Clin, 2020,38（1）:55⁃62. DOI: 10.1016/j.det.2019.08.005.
［128］	Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo［J］. Br J Dermatol, 2012,167（3）:468⁃478. DOI: 10.1111/j.1365⁃2133.2012.11008.x.
［129］	Rooney JF, Bryson Y, Mannix ML, et al. Prevention of ultraviolet⁃light⁃induced herpes labialis by sunscreen［J］. Lancet, 1991,338（8780）:1419⁃1422. DOI: 10.1016/0140⁃6736（91）92723⁃f.
［130］	Mimouni I, Shulman J, Unes AA, et al. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy［J］. Photodermatol Photoimmunol Photomed, 2024,40（1）:e12936. DOI: 10.1111/phpp.12936.
［131］	Giblin FJ, Lin L, Simpanya MF, et al. A class I UV⁃blocking （senofilcon A） soft contact lens prevents UVA⁃induced yellow fluorescence and NADH loss in the rabbit lens nucleus in vivo［J］. Exp Eye Res, 2012,102:17⁃27. DOI: 10.1016/j.exer.2012. 06.007.
［132］	Gelfand JM, Armstrong AW, Lim HW, et al. Home⁃ vs office⁃based narrowband UVB phototherapy for patients with psoriasis: the LITE randomized clinical trial［J］. JAMA Dermatol, 2024,160（12）:1320⁃1328. DOI: 10.1001/jamadermatol.2024.3897.

[1]	Hu Yu, Lu Yan, Chen Kun, Gu Heng. Standardization, precision, and full-cycle management: interpretation of Specifications for the Management of Vitiligo Patients Undergoing Home Phototherapy [J]. Chinese Journal of Dermatology, 2026, 59(7): 632-636.
[2]	Photodynamic Therapy Research Cooperative Group, Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology & Photodynamic Therapy, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Guideline for the clinical application of aminolevulinic acid-based photodynamic therapy in the treatment of condyloma acuminatum （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(7): 611-618.
[3]	Blistering Diseases Research Group, China “Belt and Road” Dermatology Alliance, Collaborative Group on Pemphigus/Bullous Pemphigoid Research, Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of anti-p200 pemphigoid （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(5): 387-395.
[4]	Hair Disease Rehabilitation Group, Chinese Association of Rehabilitation Dermatology, Hair Medicine Branch, Beijing Association of Holistic Integrative Medicine, Hair Research Group, Chinese Society of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese expert consensus on hair biopsy and pathology （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(5): 419-426.
[5]	Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on fecal microbiota transplantation in the treatment of psoriasis （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(5): 427-435.
[6]	Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on the prevention, diagnosis, and treatment of nontuberculous mycobacterial skin infections associated with medical aesthetic procedures （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 0(1): 20250537-e20250537.
[7]	Guliziba·Tuersun, Zhao Yanan, Wang Hongjuan, Kang Xiaojing, Qu Yuanyuan. Efficacy of autologous melanocyte transplantation combined with 308-nm light-emitting diode phototherapy at escalating doses in the treatment of refractory stable vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2025, 58(9): 852-856.
[8]	Zhou Miaoni, Sheng Anqi, Fu Lifang, Jin Rong, Xu Wen, Wei Xiaodong, Xu Ai′e . Efficacy and safety of an antioxidant gel containing tea polyphenols combined with narrow-band ultraviolet B in the treatment of vitiligo: a single-center randomized controlled trial [J]. Chinese Journal of Dermatology, 2025, 58(9): 834-838.
[9]	Qi-Quan CHEN Song Zhi-Qiang WANG Gang. Guidelines for the diagnosis and treatment of refractory chronic spontaneous urticaria in China （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(6): 485-496.
[10]	China Dermatologist Association, Treatment Group, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases, Rare Skin Diseases Committee, China Alliance for Rare Diseases. Diagnosis and treatment of bullous pemphigoid: an expert consensus statement （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(5): 405-415.
[11]	Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline on phototherapy for vitiligo （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(3): 197-208.
[12]	Yuan Yongyong, Pan Meng. Advances in Hailey-Hailey Disease [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240182-e20240182.
[13]	Immunology Group, Chinese Society of Dermatology. Guidelines for fecal microbiota transplantation in the treatment of immune-mediated skin diseases（2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(12): 1112-1120.
[14]	The Professional Committee on Child Health and Drug Research of the Chinese Association of Traditional Chinese Medicine. Clinical application guideline for the integration of traditional Chinese medicine and Western medicine in the prevention and treatment of infant diaper dermatitis （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(10): 893-902.
[15]	Wang Di, Zhang Ruijun, Kang Yuying. Pathogenesis and treatment of seborrheic dermatitis [J]. Chinese Journal of Dermatology, 2025, 58(1): 89-92.

Guideline for the clinical application of narrowband ultraviolet B phototherapy in dermatology （2026 edition）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［132］

Related Articles 15

Metrics

Comments

Recommended 0